Section
159 pages
话题标签
按话题浏览文章
MIBC
NEJM
Neoadjuvant
Pembrolizumab
Phase 3
Cancer Cell
Drug-Tolerant Persister
NSCLC
Osimertinib
Sacituzumab Tirumotecan
1
3
4
5
16
Jump to page
(1 - 16)
Go
Enter
Press Enter to jump